Lymphoepithelioma-Like Bladder Carcinoma: A Diagnostic and Therapeutic Challenge. Contribution Using a New Case and Review of the Literature

Clin Genitourin Cancer. 2017 Jun;15(3):e507-e515. doi: 10.1016/j.clgc.2016.12.023. Epub 2016 Dec 30.

Authors

Miguel Angel Rodríguez-Cabello¹, Santiago Méndez-Rubio², Juan Luis Sanz-Miguelañez², Javier Saenz-Medina², Pablo Garrido-Abad², Anabel Del-Barrio-Díaz-Aldagalan³, Consuelo López-Elzaurdia⁴, Arturo Platas-Sancho²

Affiliations

¹ Department of Urology, Universitary Hospital La Moraleja, Madrid, Spain. Electronic address: [email protected].
² Department of Urology, Universitary Hospital La Moraleja, Madrid, Spain.
³ Department of Oncology, Universitary Hospital La Moraleja, Madrid, Spain.
⁴ HISTOCITOMED, Laboratory of Pathology, Madrid, Spain.

PMID: 28139445
DOI: 10.1016/j.clgc.2016.12.023

No abstract available

Keywords: Bladder carcinoma; Bladder-preservation treatment; Lymphoepithelioma-like carcinoma; Prognosis of bladder carcinoma; Urinary bladder.

Publication types

Case Reports
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biomarkers, Tumor / analysis
Carcinoma, Transitional Cell / diagnosis
Carcinoma, Transitional Cell / drug therapy
Carcinoma, Transitional Cell / pathology*
Cisplatin / administration & dosage
Deoxycytidine / administration & dosage
Deoxycytidine / analogs & derivatives
Female
Gemcitabine
Humans
Middle Aged
Urinary Bladder Neoplasms / diagnosis
Urinary Bladder Neoplasms / drug therapy
Urinary Bladder Neoplasms / pathology*

Substances

Biomarkers, Tumor
Deoxycytidine
Cisplatin
Gemcitabine